Copyright
©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jan 28, 2016; 22(4): 1664-1673
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1664
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1664
Mechanisms of intrahepatic triglyceride accumulation
Claudia Ress, Susanne Kaser, Department of Internal Medicine I, Medical University Innsbruck, 6020 Innsbruck, Austria
Claudia Ress, Susanne Kaser, Christian Doppler Laboratory of Metabolic Crosstalk, Department of Internal Medicine 1, Medical University Innsbruck, 6020 Innsbruck, Austria
Author contributions: Ress C and Kaser S both conceived, wrote, and revised the manuscript and had final approval of the manuscript.
Supported by Austrian Federal Ministry of Science, Research and Economy and the National Foundation for Research, Technology and Development.
Conflict-of-interest statement: The authors declare no conflict of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Susanne Kaser, MD, Christian Doppler Laboratory of Metabolic Crosstalk, Department of Internal Medicine 1, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. susanne.kaser@i-med.ac.at
Telephone: +43-5125040 Fax: +43-512-50428539
Received: June 25, 2015
Peer-review started: June 27, 2015
First decision: July 20, 2015
Revised: August 20, 2015
Accepted: September 28, 2015
Article in press: September 30, 2015
Published online: January 28, 2016
Processing time: 208 Days and 18.3 Hours
Peer-review started: June 27, 2015
First decision: July 20, 2015
Revised: August 20, 2015
Accepted: September 28, 2015
Article in press: September 30, 2015
Published online: January 28, 2016
Processing time: 208 Days and 18.3 Hours
Core Tip
Core tip: Fatty liver disease is a highly prevalent condition in the Western World. This article summarizes the most frequent causes and states of hepatic steatosis, including non-alcoholic fatty liver disease (NAFLD), alcoholic fatty liver, drug-induced forms, hepatitis C virus infections, and acute fatty liver of pregnancy. Important pathophysiological and cellular aspects of various forms of fatty liver disease are reviewed as well as the clinically relevant close interaction between hepatic triglyceride accumulation and insulin resistance in NAFLD.